Lack of Evidence for an Increased Risk of Severe COVID-19 in Psoriasis Patients on Biologics: A Cohort Study from Northeast Italy

Am J Clin Dermatol. 2020 Oct;21(5):749-751. doi: 10.1007/s40257-020-00552-w.

Authors

Stefano Piaserico¹, Paolo Gisondi², Simone Cazzaniga^{3

4}, Luigi Naldi^{3

5}

Affiliations

¹ Unit of Dermatology, Department of Medicine, University of Padua, via Gallucci 4, 35128, Padova, Italy. stefano.piaserico@unipd.it.
² Department of Medicine, Section of Dermatology and Venereology, University of Verona, Verona, Italy.
³ Centro Studi GISED, Bergamo, Italy.
⁴ Inselspital University Hospital of Bern, Bern, Switzerland.
⁵ Department of Dermatology, San Bortolo Hospital, Vicenza, Italy.

No abstract available

Publication types

Letter

MeSH terms

Adult
Aged
Betacoronavirus
Biological Therapy / adverse effects*
COVID-19
Cohort Studies
Coronavirus Infections / epidemiology
Coronavirus Infections / etiology*
Female
Humans
Italy / epidemiology
Male
Middle Aged
Pandemics
Pneumonia, Viral / epidemiology
Pneumonia, Viral / etiology*
Psoriasis / drug therapy*
SARS-CoV-2
Tumor Necrosis Factor Inhibitors / adverse effects*
Young Adult

Substances

Tumor Necrosis Factor Inhibitors